small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (219)
  • Capabilities (58)
  • Experience (139)
  • Insights & News (1,430)
  • Other Results (66)

Professionals 219 results

T. Reed Stephens
T. Reed Stephens
Partner
  • Washington, DC
Email
+1 202-282-5795
vCard

Partner

  • Washington, DC
Joelle Ross
Joelle Ross
Associate
  • Washington, DC, 
  • Chicago
Email
+1 202-282-5702
vCard

Associate

  • Washington, DC
  • Chicago
Kevin Boyle
Kevin Boyle
Associate
  • Chicago
Email
+1 312-558-8138
vCard

Associate

  • Chicago
View All Professionals

Capabilities 58 results

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Industry

Artificial Intelligence (AI)

Practice Area

Privacy: Regulated Personal Information (RPI)

Winston’s Regulated Personal Information (RPI) Practice offers seamlessly integrated counseling and litigation services to companies looking for practical and solution-oriented assistance navigating the compliance, regulatory, and private class action enforcement risks presented by the emerging patchwork of complex (and often conflicting) privacy laws in the United States and beyond....Read more

Experience 139 results

Experience

|

May 27, 2025

PicoCELA Inc. Closes $1.8 Public Offering

Experience

|

April 11, 2025

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

Experience

|

April 10, 2025

Titan Acquisition Corp Announces Closing of $276,000,000 Initial Public Offering

View All Experience

Insights & News 1,430 results

Client Alert

|

June 3, 2025

|

6 Min Read

“SEC Speaks” Shift in Regulatory and Philosophy Priorities

On May 19 and 20, senior leadership and other representatives from the Securities and Exchange Commission (SEC) presented at Practising Law Institute’s The SEC Speaks conference. SEC leadership delivered comprehensive remarks articulating a clear shift in the SEC’s regulatory philosophy and priorities and outlining the agency’s evolving approach to regulation and enforcement. We previously covered updates related to the Division of Enforcement here. 

Recognitions

|

May 30, 2025

|

Less Than 1 Min Read

Susannah Torpey Named to Global Competition Review’s 2025 Women in Antitrust List

Winston & Strawn partner and co-chair of the firm’s Technology Antitrust Group Susannah Torpey was named as one of Global Competition Review’s Women in Antitrust in 2025. This survey highlights 62 newly recognized women and 89 returning leaders, celebrating their influence, professional achievements, and growing representation in the field of antitrust. Susannah shares insights on the evolving landscape of antitrust and underrepresentation of women in antitrust litigation....Read more

Investigations, Enforcement, & Compliance Alerts

|

May 30, 2025

|

4 Min Read

Supreme Court Rules Wire Fraud Prosecutions Can Stand Even in Those Cases in Which the Defendant Did Not Seek to Cause Economic Loss

On May 22, 2025, the Supreme Court issued its opinion in Kousisis v. United States, holding that the government need not prove an intent to cause economic loss, let alone actual economic loss, in order to sustain a conviction for wire fraud under 18 U.S.C. § 1343. 

View All Insights & News

Other Results 66 results

Law Glossary

What Is a Generic Drug?

Generic drugs are typically small, chemically synthesized molecules—that is, they have relatively low molecular weights, frequently less than 1000 daltons and usually between 300 and 700 daltons. Biosimilars, on the other hand, are typically substantially larger in molecular weight than small molecule drugs. For example, a monoclonal antibody—a typical biosimilar drug—generally has a molecular weight in excess of 150,000 daltons. In contrast, aspirin—a typical small molecule drug—has a molecular weight of 180 daltons....Read more

Law Glossary

What Is a Biologic?

A biologic—or biologic product—is a medicine made from or by living cells, typically through a series of complex processing steps. The Public Health Service Act defines a “biological product” as “a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or another trivalent organic arsenic compound), applicable to the prevention, treatment, or cure of a disease or condition of human beings.” (42 U.S.C. § 262(i).)...Read more

Law Glossary

What Is a Qualified Retirement Plan?

A qualified retirement plan is a retirement plan established by an employer that is designed to provide retirement income to designated employees and their beneficiaries, which meets certain IRS Code requirements in terms of both form and operation. Common plan types are 401(k) plans, pension plans, and profit-sharing plans. A qualified retirement plan may allow for both employer and employee contributions. Employers must follow procedures to ensure participants and beneficiaries are able to receive their benefits. They must also stay apprised of changes in retirement plan laws and regulations. Qualified retirement plans provide certain tax advantages to employers and tax deferral advantages to employees who are contributing. Taxes on earnings from the contributions are also deferred until the employee withdraws them from the plan....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising